thiazoles has been researched along with Cell Transformation, Neoplastic in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (14.08) | 18.7374 |
1990's | 6 (8.45) | 18.2507 |
2000's | 17 (23.94) | 29.6817 |
2010's | 38 (53.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
Choi, MJ; Ham, SA; Han, SG; Hwang, JS; Kim, E; Lee, CH; Lee, WJ; Paek, KS; Seo, HG; Yoo, T; Youn, JH | 1 |
Bai, WL; Ji, WY; Song, Y; Sun, X | 1 |
Anastasiadis, PZ; Carlson, BL; Galanis, E; Giannini, C; Huveldt, D; Lewis-Tuffin, LJ; Rodriguez, F; Sarkaria, JN; Schroeder, MA | 1 |
Kabadere, S; Kus, G; Oztopcu-Vatan, P; Uyar, R | 1 |
Kurosu, T; Miura, O; Nagao, T; Nogami, A; Oshikawa, G; Tohda, S; Umezawa, Y; Yamamoto, M | 1 |
Bailey, ST; Clark, K; Damrauer, JS; Darr, D; Diehn, M; Fan, C; Hadzic, T; Jeong, Y; Jin, J; Kim, WY; Lee, CY; Levine, RL; Miller, CR; Murphy, L; Perou, CM; Troester, MA; Zhou, B | 1 |
Beristain, AG; Chang, MC; Di Grappa, MA; Joshi, PA; Khokha, R; Kirschner, LS; Molyneux, SD; Pomroy, NC; Privé, GG; Pujana, MA | 1 |
Agopian, J; Bertucci, F; Chauvot de Beauchêne, I; De Sepulveda, P; Dubreuil, P; Fouet, B; Fournier, B; Mescam-Mancini, L; Panel, N; Tchertanov, L; Tisserand, JC; Vita, M | 1 |
Blijlevens, M; Frangou, C; Guo, J; Li, YW; Nowak, NJ; Shen, H; Wilson, KE; Yang, N; Zhang, J | 1 |
Huang, CM; Huang, FC; Li, P; Li, Y; Lin, X; Lu, J; Wang, JB; Xie, JW; Zhang, JR; Zheng, CH | 1 |
Balandaram, G; Gonzalez, FJ; Kang, BH; Kramer, LR; Murray, IA; Perdew, GH; Peters, JM | 1 |
Andrisani, OM; Bi, P; Bidwell, CA; Castro, B; Durkes, A; Elzey, BD; Freeman, JL; Karki, A; Konieczny, SF; Kuang, S; Wang, C; Wirbisky, SE; Yue, F | 1 |
Bomann, W; Cohen, SM; Strupp, C; Weber, K | 1 |
Fan, JH; He, DL; Li, L; Li, X; Wang, XY; Wu, DP; Wu, KJ; Zhang, LL | 1 |
Bility, MT; Blazanin, N; Devlin-Durante, MK; Glick, AB; Gonzalez, FJ; Kang, BH; Kennett, MJ; Peters, JM; Ward, JM | 1 |
Sos, ML; Thomas, RK | 1 |
Kasada, A; Munemoto, S; Murata, R; Ueda, M; Yamaguchi, M | 1 |
Banerjee, S; Kanwar, SS; Majumdar, AP; Nautiyal, J; Patel, BB; Sarkar, FH; Yu, Y | 1 |
Abdulkadir, SA; Kim, J; Roh, M | 1 |
Dempke, W; Zippel, R | 1 |
Babic, I; Cai, H; Huang, J; Wei, X; Witte, ON | 1 |
Liang, R; Rubin, BP; Schadendorf, D; Wallace, AR | 1 |
Bareford, MD; Cruickshanks, N; Dai, Y; Dent, P; Grant, S; Hamed, HA; Hubbard, N; Mitchell, C; Tang, Y; Tye, G; Yacoub, A | 1 |
Kim, DK; Park, CY; Sheen, YY | 1 |
Osanai, M | 1 |
Cowell, JK; Qin, H; Ren, M; Ren, R; Tidwell, J | 1 |
Cho, HG; Choi, HS; Kang, BS; Khanal, P; Makarieva, TN; Yun, HJ | 1 |
Bhatia, R; Chen, WY; Roth, M; Wang, Z; Yuan, H; Zhang, H | 1 |
Asa, SL; Ezzat, S; Mayr, T; Tateno, T; Ullrich, A; Zheng, L | 1 |
Gao, Y; Jiang, H; Li, Q; Xu, ZG; Yu, YY; Zhu, ZG | 1 |
Ansén, S; Bass, AJ; Beer, DG; Brace, LE; Brambilla, C; Brambilla, E; Brustugun, OT; Cho, J; Clement, JH; Deng, X; Dutt, A; Eck, MJ; Gabler, F; Gray, NS; Greulich, H; Groen, H; Hammerman, PS; Hanna, M; Hatton, C; Haura, EB; Helland, A; Heuckmann, JM; Heynck, S; Janne, PA; Johnson, BE; Koker, M; Lawrence, MS; Leenders, F; Lim, SM; Lin, W; Lorimier, P; Meyerson, M; Moch, H; Onofrio, RC; Peifer, M; Petersen, I; Querings, S; Ramos, AH; Rauh, D; Salvesen, HB; Seidel, D; Sietsma, H; Simard, JR; Soltermann, A; Sos, ML; Stoelben, E; Thomas, RK; Timens, W; Tsao, MS; Winckler, W; Wolf, J; Wong, KK; Woods, BA; Xu, C; Zander, T; Zhang, J; Zhou, W | 1 |
Brilli, E; Caldera, V; Cattaneo, E; Conforti, P; Conti, L; Crisafulli, L; Magrassi, L; Schiffer, D; Tortoreto, M; Zunino, F | 1 |
Beard, L; Carlin, C; Guo, A; Markowitz, SD; Polakiewicz, RD; Possemato, A; Wang, C; Wang, Z; Zhang, P | 1 |
Fu, J; Hu, Y; Liu, L; Yang, X; Zhang, Z | 1 |
Aktas, BH; Chen, L; Chorev, M; Denoyelle, S; Freedman, RY; Halperin, JA; He, X; Kabha, E; Sahoo, R; Supko, JG; Wagner, G; Wang, Y; Yang, H; Zhang, N | 1 |
Badura, S; Khateb, M; Mahajna, J; Metodieva, A; Mian, AA; Najajreh, Y; Ottmann, OG; Ruimi, N; Ruthardt, M | 1 |
Bonner, JC; Newman, DR; Sannes, PL; Zhang, H | 1 |
Chen, X; Duan, L; He, T; Luo, J; Shi, Q; Tang, M; Wang, H; Weng, Y; Wu, R; Yang, X; Ye, L; Zhang, Y; Zhou, L | 1 |
Choi, HK; Kang, KW; Quyen, BT | 1 |
Liu, S; Ouchi, T; Saeki, T; Shionome, Y; Yan, L | 1 |
LaMont, JT; Li, CJ; Li, Y; Pardee, AB; Sun, X | 1 |
Herbert, BS; Hynan, LS; Kopelovich, L; LaRue, DM; Pearce, VP; Shay, JW; Wright, WE | 1 |
Almahmeed, T; Boyle, JO; Cohen, EG; Dannenberg, AJ; Du, B; Golijanin, D; Soslow, RA; Subbaramaiah, K | 1 |
Chou, FP; Chou, MY; Hsu, JD; Huang, HP; Lin, MH; Wang, CJ | 1 |
Acs, G; Elder, DE; Fang, D; Herlyn, M; Kumar, SM; Xu, X | 1 |
Aoki, T; Endo, M; Itoi, T; Kasuya, K; Katsumata, K; Suzuki, M; Tsuchida, A | 1 |
Duffy, TM; Hu, Y; Lee, FY; Li, S; Swerdlow, S; Weinmann, R | 1 |
Aktas, H; Cantel, S; Chen, H; Chorev, M; Degterev, A; Fahmy, A; Gross, JD; Halperin, JA; Moerke, NJ; Reibarkh, MY; Wagner, G; Yuan, J | 1 |
Amin, S; Billin, AN; Borland, MG; Girroir, EE; Gonzalez, FJ; Hollingshead, HE; Killins, RL; Peters, JM; Sharma, AK; Willson, TM | 1 |
Choi, HS; Dong, Z; Ermakova, SP; Kang, KW; Lee, NY; Zvyagintseva, TN | 1 |
Brugarolas, A; Gosalvez, M | 1 |
McCarty, MF | 1 |
Coppey, J; Magdelenat, H; Rigaud, O | 1 |
Brusick, DJ; Galloway, SM; Hinderer, RK; Jagannath, DR; Mann, SW; Myhr, B; Riddle, JC | 1 |
Blanco, MF; de Paz, E; Gosálvez, M | 1 |
Banks, AR; Hessek, E; Jones, T; Parks, RC | 1 |
Gosalvez, M | 1 |
Morishita, H; Tanaka, M; Tomita, K; Tsuchiya, H; Ueda, Y | 1 |
Ishida, T; Kuroda, M; Machinami, R; Satoh, M; Takanashi, M; Watanabe, T | 1 |
Hiwasa, T; Ike, Y; Tokita, H | 1 |
Auwerx, J; Fruchart, JC; Gelman, L | 1 |
Drebin, JA; Greene, MI; Montone, KT; Murali, R; Peavey, JE; Wang, Q; Zhang, H | 1 |
Medina, G; Puig, AJ; Sewter, C | 1 |
Bury, M; Młynarczuk, I; Pleban, E; Wójcik, C | 1 |
Oda, T; Sasaki, T; Tanaka, M | 1 |
DuBois, RN; Shao, J; Sheng, H | 1 |
Alroy, J; Friedell, GH; Jacobs, JB; Merk, FB; Pauli, BU; Weinstein, RS | 1 |
Burdon, RH; Gill, V; Rice-Evans, C | 1 |
Cui, XX | 1 |
Heckl, W; Jocham, K; Täuber, J; Vohr, HW | 1 |
5 review(s) available for thiazoles and Cell Transformation, Neoplastic
Article | Year |
---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
[SRC kinases in tumor therapy].
Topics: Aniline Compounds; Benzodioxoles; Cell Physiological Phenomena; Cell Transformation, Neoplastic; Clinical Trials, Phase II as Topic; Dasatinib; Disease Progression; DNA Mutational Analysis; Drug Delivery Systems; Enzyme Activation; Humans; Neoplasms; Nitriles; Protein Kinase Inhibitors; Proto-Oncogene Mas; Pyrimidines; Quinazolines; Quinolines; src-Family Kinases; Thiazoles | 2010 |
Cytostatic and reverse-transforming therapies of cancer - a brief review and future prospects.
Topics: Animals; Antineoplastic Agents; Benzaldehydes; Cell Transformation, Neoplastic; Cyclic AMP; Growth Inhibitors; Humans; Interferons; Neoplasms; Protease Inhibitors; Solvents; Thiazoles; Thiazolidines; Vitamin A | 1982 |
An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer.
Topics: Adipocytes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Cycle; Cell Differentiation; Cell Transformation, Neoplastic; Colonic Neoplasms; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Homeostasis; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Intestinal Mucosa; Lipid Metabolism; Macrophages; Neoplasms; Peroxisome Proliferators; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Thiazoles; Transcription Factors | 1999 |
[PPARgamma and thiazolidinediones, something more than a treatment for diabetes].
Topics: Arteriosclerosis; Cell Differentiation; Cell Transformation, Neoplastic; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Hypoglycemic Agents; Ligands; Male; Polycystic Ovary Syndrome; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 2000 |
1 trial(s) available for thiazoles and Cell Transformation, Neoplastic
66 other study(ies) available for thiazoles and Cell Transformation, Neoplastic
Article | Year |
---|---|
Ligand-activated interaction of PPARδ with c-Myc governs the tumorigenicity of breast cancer.
Topics: A549 Cells; Animals; Breast Neoplasms; Carcinogenesis; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Humans; Ligands; MCF-7 Cells; PC12 Cells; PPAR delta; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc; Rats; RNA, Small Interfering; Thiazoles | 2018 |
Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cisplatin; Dasatinib; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Vitro Techniques; Laryngeal Neoplasms; Male; Mice; Mice, Nude; Neoplasm Transplantation; Protein Kinase Inhibitors; Pyrimidines; Rats; Thiazoles | 2013 |
Targeting Src family kinases inhibits bevacizumab-induced glioma cell invasion.
Topics: Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; Enzyme Activation; Glioma; Humans; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles | 2013 |
Licofelone abolishes survival of carcinogenic fibroblasts by inducing apoptosis.
Topics: Analysis of Variance; Animals; Apoptosis; Cell Transformation, Neoplastic; DNA Primers; Dose-Response Relationship, Drug; Embryo, Mammalian; Fibroblasts; Flow Cytometry; Fluorouracil; Pyrroles; Rats; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors; Trypan Blue; Tumor Cells, Cultured | 2014 |
Proliferation and survival signaling from both Jak2-V617F and Lyn involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 cell line newly established from acute myeloid leukemia transformed from polycythemia vera.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Bone Marrow; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Dasatinib; DNA Mutational Analysis; Female; Glycogen Synthase Kinase 3; Humans; Janus Kinase 2; Karyotype; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Phosphoproteins; Phosphorylation; Polycythemia Vera; Protein Kinase Inhibitors; Pyrimidines; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; src-Family Kinases; Thiazoles | 2014 |
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Disease Progression; Disease-Free Survival; Endothelial Cells; Erythropoietin; Female; Gene Expression Regulation; Humans; Hypoxia; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplastic Stem Cells; Recurrence; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors | 2014 |
PKA signaling drives mammary tumorigenesis through Src.
Topics: Androstadienes; Animals; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Dasatinib; Epithelial Cells; Female; Humans; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Phosphorylation; Pyrimidines; Signal Transduction; src-Family Kinases; Thiazoles; Wortmannin | 2015 |
Characterization of S628N: a novel KIT mutation found in a metastatic melanoma.
Topics: Aged, 80 and over; Animals; Benzamides; Cell Transformation, Neoplastic; Cells, Cultured; Colony-Forming Units Assay; Dasatinib; Fatal Outcome; Female; Fibroblasts; Humans; Imatinib Mesylate; Lung Neoplasms; Melanoma; Mutation, Missense; Phosphorylation; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines; Rats; Skin Neoplasms; Spinal Neoplasms; Thiazoles | 2014 |
Molecular profiling and computational network analysis of TAZ-mediated mammary tumorigenesis identifies actionable therapeutic targets.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; Flow Cytometry; Heterografts; Humans; Intracellular Signaling Peptides and Proteins; Mice; Mice, SCID; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Thiazoles; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins; Transcriptome; Transduction, Genetic; Transfection; Triple Negative Breast Neoplasms | 2014 |
The expression of presenilin 1 enhances carcinogenesis and metastasis in gastric cancer.
Topics: Actin Cytoskeleton; Animals; beta Catenin; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Diamines; Enzyme Activation; Female; Humans; Lymphatic Metastasis; Lymphoid Enhancer-Binding Factor 1; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Invasiveness; Presenilin-1; Stomach Neoplasms; TCF Transcription Factors; Thiazoles | 2016 |
Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Topics: Alanine Transaminase; Animals; Apoptosis; Cell Proliferation; Cell Transformation, Neoplastic; Hepatitis B; Hepatocytes; Kupffer Cells; Ligands; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Polymerase Chain Reaction; PPAR delta; PPAR-beta; Thiazoles | 2016 |
Notch activation drives adipocyte dedifferentiation and tumorigenic transformation in mice.
Topics: Adipocytes; Animals; Biomarkers, Tumor; Cell Dedifferentiation; Cell Differentiation; Cell Lineage; Cell Proliferation; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diamines; Dibenzazepines; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Ligands; Lipid Metabolism; Liposarcoma; Metabolic Syndrome; Mice, Inbred C57BL; PPAR gamma; Precancerous Conditions; PTEN Phosphohydrolase; Receptors, Notch; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Xenograft Model Antitumor Assays | 2016 |
Relationship of Metabolism and Cell Proliferation to the Mode of Action of Fluensulfone-Induced Mouse Lung Tumors. II: Additional Mechanistic Studies.
Topics: Activation, Metabolic; Adenoma; Animals; Cell Proliferation; Cell Transformation, Neoplastic; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Female; Humans; Lung; Lung Neoplasms; Male; Mice, Inbred C57BL; Mice, Knockout; Pesticides; Risk Assessment; Species Specificity; Sulfones; Thiazoles; Time Factors | 2016 |
A novel anti-cancer effect of genistein: reversal of epithelial mesenchymal transition in prostate cancer cells.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Epithelial Cells; Genistein; Humans; Male; Neoplasm Invasiveness; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles | 2008 |
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.
Topics: Acetone; Animals; Carcinogens; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Enzyme Activation; Female; Keratinocytes; Ligands; Mice; Mice, Mutant Strains; PPAR delta; PPAR-beta; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thiazoles | 2008 |
Systematically linking drug susceptibility to cancer genome aberrations.
Topics: Benzoquinones; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mutation; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; Thiazoles | 2009 |
Successful treatment using low-dose dasatinib for chronic myelogenous leukemia in a patient with megakaryoblastic transformation concomitant with myelofibrosis and an extramedullary tumor.
Topics: Aged; Antineoplastic Agents; Cell Transformation, Neoplastic; Dasatinib; Dose-Response Relationship, Drug; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Primary Myelofibrosis; Pyrimidines; Thiazoles | 2010 |
Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells.
Topics: Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Agents; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Colonic Neoplasms; CSK Tyrosine-Protein Kinase; Curcumin; Dasatinib; Drug Synergism; Electrophoretic Mobility Shift Assay; Endothelium, Vascular; ErbB Receptors; Female; Humans; Immunoenzyme Techniques; Intestinal Neoplasms; Mice; Mice, Knockout; Neoplasm Invasiveness; Neovascularization, Pathologic; NF-kappa B; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptor, IGF Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; src-Family Kinases; Thiazoles; Umbilical Veins | 2011 |
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-pim-1; Receptors, Androgen; RNA Interference; RNA, Messenger; Thiazoles; Time Factors; Transcriptional Activation; Transfection; Tumor Burden; Up-Regulation | 2010 |
Invasive prostate carcinoma driven by c-Src and androgen receptor synergy.
Topics: Animals; Cell Transformation, Neoplastic; CSK Tyrosine-Protein Kinase; Dasatinib; Epithelial-Mesenchymal Transition; Male; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Receptors, Androgen; Signal Transduction; src-Family Kinases; Thiazoles; Up-Regulation | 2011 |
The phosphatidyl inositol 3-kinase pathway is central to the pathogenesis of Kit-activated melanoma.
Topics: Animals; Benzamides; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; Enzyme Activation; Humans; Imatinib Mesylate; Melanocytes; Melanoma; Mice; Models, Biological; Mutant Proteins; Phosphatidylinositol 3-Kinase; Piperazines; Proto-Oncogene Proteins c-kit; Pyrimidines; Reproducibility of Results; Signal Transduction; Thiazoles | 2011 |
Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death.
Topics: Animals; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-X Protein; Benzimidazoles; Benzodioxoles; Breast Neoplasms; Cell Death; Cell Line, Transformed; Cell Transformation, Neoplastic; Checkpoint Kinase 1; Dasatinib; Female; Fibroblasts; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Protease Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-yes; Pyrimidines; Quinazolines; Radiation Tolerance; src-Family Kinases; Thiazoles | 2011 |
EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Epithelial Cells; Epithelial-Mesenchymal Transition; Female; Humans; Lung Neoplasms; Mammary Glands, Animal; Mammary Glands, Human; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Thiazoles; Transforming Growth Factor beta; Xenograft Model Antitumor Assays | 2011 |
The tight junction, intercellular seal as a cell signaling player: protocols for examination of its status.
Topics: Apoptosis; Blotting, Western; Cell Culture Techniques; Cell Line, Tumor; Cell Transformation, Neoplastic; Cells, Cultured; Claudins; Colony-Forming Units Assay; Female; Humans; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Microarray Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Tetrazolium Salts; Thiazoles; Tight Junctions | 2011 |
Src activation plays an important key role in lymphomagenesis induced by FGFR1 fusion kinases.
Topics: 3T3 Cells; Animals; Cell Death; Cell Growth Processes; Cell Line, Tumor; Cell Transformation, Neoplastic; Cells, Cultured; Dasatinib; DNA-Binding Proteins; Female; Humans; Leukemia; Lymphoma, B-Cell; Lymphoma, T-Cell; Membrane Proteins; Mice; Mice, Inbred BALB C; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcr; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 1; Signal Transduction; src-Family Kinases; Thiazoles; Transcription Factors; Translocation, Genetic | 2011 |
Aglycon of rhizochalin from the Rhizochalina incrustata induces apoptosis via activation of AMP-activated protein kinase in HT-29 colon cancer cells.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Transformation, Neoplastic; Chemoprevention; Colonic Neoplasms; DNA Fragmentation; Drug Evaluation, Preclinical; Extracellular Signal-Regulated MAP Kinases; Fatty Alcohols; Glycosphingolipids; HT29 Cells; Humans; Mice; Mitogen-Activated Protein Kinases; Molecular Targeted Therapy; Oceans and Seas; Phosphorylation; Phytotherapy; Plant Preparations; Poly(ADP-ribose) Polymerases; Porifera; Protein Serine-Threonine Kinases; Tetrazolium Salts; Thiazoles; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2011 |
Overcoming CML acquired resistance by specific inhibition of Aurora A kinase in the KCL-22 cell model.
Topics: Apoptosis; Aurora Kinases; Benzamides; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Dasatinib; Down-Regulation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Gene Knockdown Techniques; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mitosis; Piperazines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles | 2012 |
The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis.
Topics: Animals; Cell Transformation, Neoplastic; Dasatinib; Gene Expression Regulation, Neoplastic; Gene Knock-In Techniques; Genes, src; Growth Hormone; Humans; Mice; Mitochondria; Phosphorylation; Pituitary Neoplasms; Polymorphism, Single Nucleotide; Prolactin; Pyrimidines; Rats; Receptor, Fibroblast Growth Factor, Type 4; Serine; STAT3 Transcription Factor; Thiazoles | 2011 |
Effect of antisense oligodeoxynucleotide targeted against NF-κB/P65 on cell proliferation and tumorigenesis of gastric cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Disease Models, Animal; Humans; Mice; Mice, Nude; Oligodeoxyribonucleotides, Antisense; Staining and Labeling; Stomach Neoplasms; Tetrazolium Salts; Thiazoles; Transcription Factor RelA | 2013 |
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Transformation, Neoplastic; Dasatinib; Discoidin Domain Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Mice; Mice, Nude; Mutation; NIH 3T3 Cells; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; src-Family Kinases; Thiazoles | 2011 |
REST controls self-renewal and tumorigenic competence of human glioblastoma cells.
Topics: Analysis of Variance; Animals; Annexin A5; Apoptosis; Blotting, Western; Cell Transformation, Neoplastic; Colorimetry; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glioblastoma; Humans; Immunohistochemistry; In Vitro Techniques; Mice; Mice, SCID; MicroRNAs; Real-Time Polymerase Chain Reaction; Repressor Proteins; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2012 |
Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14.
Topics: Amino Acid Sequence; Animals; Cell Transformation, Neoplastic; Colorectal Neoplasms; Crk-Associated Substrate Protein; Dasatinib; Epidermal Growth Factor; Female; Gene Knock-In Techniques; HCT116 Cells; HEK293 Cells; HT29 Cells; Humans; Mice; Mice, Nude; Molecular Sequence Data; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatases, Non-Receptor; Pyrimidines; Signal Transduction; Thiazoles; Transplantation, Heterologous | 2013 |
MicroRNA155 in the growth and invasion of salivary adenoid cystic carcinoma.
Topics: Animals; Carcinoma, Adenoid Cystic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Coloring Agents; Disease Models, Animal; Electrophoretic Mobility Shift Assay; ErbB Receptors; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Middle Aged; Neoplasm Invasiveness; NF-kappa B; Parotid Gland; Polymerase Chain Reaction; Salivary Gland Neoplasms; Tetrazolium Salts; Thiazoles; Transcription Factor RelA | 2013 |
Tumor suppression by small molecule inhibitors of translation initiation.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Eukaryotic Initiation Factor-2; Eukaryotic Initiation Factor-4F; Female; Humans; Hydrazones; Indoles; Male; Melanoma; Mice; Mice, Nude; Nitro Compounds; Peptide Chain Initiation, Translational; Phosphorylation; Protein Biosynthesis; RNA, Messenger; Thiazoles; Xenograft Model Antitumor Assays | 2012 |
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I.
Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; Colony-Forming Units Assay; Dasatinib; Female; Fusion Proteins, bcr-abl; Gene Expression; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mutation; Protein Kinase Inhibitors; Pyrimidines; Thiazoles | 2012 |
Over-expression of human endosulfatase-1 exacerbates cadmium-induced injury to transformed human lung cells in vitro.
Topics: Adenoviridae; Apoptosis; Blotting, Western; Cadmium; Cell Count; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Coloring Agents; Down-Regulation; Heparan Sulfate Proteoglycans; Humans; In Situ Nick-End Labeling; Lac Operon; Lung; Polymerase Chain Reaction; Respiratory Mucosa; Sulfotransferases; Tetrazolium Salts; Thiazoles; Transduction, Genetic; Up-Regulation | 2012 |
S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
Topics: Animals; Calgranulin B; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Female; Flavonoids; Hep G2 Cells; Humans; Imidazoles; Liver Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Transplantation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Random Allocation; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2013 |
Pin1 is required for ultraviolet A-stimulated cyclooxygenase-2 induction in mouse epidermal cells.
Topics: Animals; CCAAT-Enhancer-Binding Proteins; Cell Line; Cell Transformation, Neoplastic; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Enzyme Activation; Enzyme Induction; Epidermal Growth Factor; Epidermis; Epithelial Cells; Meloxicam; Mice; Naphthoquinones; NF-kappa B; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Signal Transduction; Thiazines; Thiazoles; Transcription Factor AP-1; Ultraviolet Rays | 2013 |
Integrity of p53 associated pathways determines induction of apoptosis of tumor cells resistant to Aurora-A kinase inhibitors.
Topics: Animals; Apoptosis; Aurora Kinase A; Aurora Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Drug Resistance, Neoplasm; Female; HCT116 Cells; Humans; Mice; Neoplasms; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2013 |
Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Death; Cell Division; Cell Line; Cell Transformation, Neoplastic; Coloring Agents; DNA-Binding Proteins; Dose-Response Relationship, Drug; E2F Transcription Factors; E2F1 Transcription Factor; Flow Cytometry; Humans; Models, Biological; Naphthoquinones; Neoplasms; Retinoblastoma Protein; S Phase; Tetrazolium Salts; Thiazoles; Transcription Factors; Tumor Cells, Cultured | 2003 |
A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Breast; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Li-Fraumeni Syndrome; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Telomere; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma.
Topics: Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Neoplastic; Coloring Agents; Head and Neck Neoplasms; Humans; Immunoblotting; Immunohistochemistry; Intramolecular Oxidoreductases; Microsomes; Mucous Membrane; Prognosis; Prostaglandin-E Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles; Time Factors | 2003 |
The tumor promoting effect of lime-piper betel quid in JB6 cells.
Topics: Animals; Areca; Calcium Compounds; Carcinogenicity Tests; Carcinogens; Cell Cycle; Cell Line; Cell Transformation, Neoplastic; Citrus aurantiifolia; G1 Phase; Hydrogen Peroxide; Mice; Ornithine Decarboxylase; Oxides; Peroxidase; Piper; Plant Extracts; S Phase; Tetrazolium Salts; Thiazoles | 2003 |
Functional erythropoietin autocrine loop in melanoma.
Topics: Blotting, Western; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Cobalt; Coloring Agents; Culture Media, Conditioned; Disease Progression; Dose-Response Relationship, Drug; Erythropoietin; Humans; Hypoxia; Immunohistochemistry; MAP Kinase Signaling System; Melanocytes; Melanoma; Membrane Potentials; Mitochondria; Phosphorylation; Receptors, Erythropoietin; Tetrazolium Salts; Thiazoles; Trypan Blue | 2005 |
Inhibitory effect of meloxicam, a cyclooxygenase-2 inhibitor, on N-nitrosobis (2-oxopropyl) amine induced biliary carcinogenesis in Syrian hamsters.
Topics: Animals; Apoptosis; Carcinogens; Carcinoma in Situ; Cell Proliferation; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Epithelium; Female; Gallbladder; Gallbladder Neoplasms; Hyperplasia; Meloxicam; Mesocricetus; Nitrosamines; Proliferating Cell Nuclear Antigen; Thiazines; Thiazoles | 2005 |
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.
Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Benzamides; Blast Crisis; Burkitt Lymphoma; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles | 2006 |
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
Topics: Animals; Antineoplastic Agents; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Evaluation, Preclinical; Eukaryotic Initiation Factor-4E; Eukaryotic Initiation Factor-4G; Feedback, Physiological; Fluorescence Polarization Immunoassay; Gene Expression Regulation, Neoplastic; Humans; Hydrazones; Jurkat Cells; Mice; Models, Molecular; Nitro Compounds; Oncogenes; Peptide Fragments; Protein Binding; Protein Biosynthesis; RNA, Messenger; Thiazoles | 2007 |
Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Colon; Colonic Polyps; Culture Media, Serum-Free; Cyclooxygenase 2; Humans; Ligands; Liver; Mice; Mice, Inbred C57BL; Phosphorylation; PPAR delta; PPAR-beta; Proto-Oncogene Proteins c-akt; Thiazoles; Vascular Endothelial Growth Factor A | 2007 |
Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells.
Topics: Animals; Antineoplastic Agents; Biotransformation; Blotting, Western; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Chromatography, Ion Exchange; Epidermal Growth Factor; ErbB Receptors; Genes, fos; Genes, jun; Genes, Reporter; Indicators and Reagents; Laminaria; Mice; Phosphorylation; Polysaccharides; Signal Transduction; Tetrazolium Salts; Thiazoles; Transcription Factor AP-1 | 2008 |
Treatment of cancer by an inducer of reverse transformation.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carboxylic Acids; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Neoplasms; Thiazoles; Thiazolidines | 1980 |
Lack of reverse transformation after treatment of A 549 human alveolar carcinoma cells with thioproline.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Cell Division; Cell Line; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Phenotype; Thiazoles; Thiazolidines | 1983 |
Mutagenic evaluations of four rubber accelerators in a battery of in vitro mutagenic assays.
Topics: Benzothiazoles; Cell Line; Cell Transformation, Neoplastic; Chromosome Aberrations; Clone Cells; DNA Repair; Escherichia coli; Humans; Lymphoma; Morpholines; Mutagens; Neoplasms, Experimental; Oxazines; Rubber; Salmonella; Thiazoles | 1983 |
[Transrecters. A new group of inducers of reverse transformation with possible use in the treatment of human cancer].
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; HeLa Cells; Humans; Neoplasms; Thiazoles; Thiazolidines | 1982 |
Thioproline: an inhibitor of chemical carcinogenesis.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Female; Methylcholanthrene; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Thiazoles; Thiazolidines | 1982 |
On the irreproducibility of thioproline.
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Drug Synergism; HeLa Cells; Humans; Thiazoles; Thiazolidines | 1982 |
Differentiating and antitumor activities of 1 alpha,25-dihydroxyvitamin D3 in vitro and 1 alpha-hydroxyvitamin D3 in vivo on human osteosarcoma.
Topics: Adolescent; Alkaline Phosphatase; Animals; Antineoplastic Agents; Bone Neoplasms; Calcitriol; Cell Transformation, Neoplastic; Cisplatin; Culture Media; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxycholecalciferols; Mice; Mice, Nude; Osteocalcin; Osteosarcoma; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1993 |
Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.
Topics: Adipocytes; Animals; CCAAT-Enhancer-Binding Proteins; Cell Differentiation; Cell Transformation, Neoplastic; Cells, Cultured; Chloramphenicol O-Acetyltransferase; DNA-Binding Proteins; DNA, Complementary; Gene Expression; Insulin; Mice; Mice, Nude; Neoplasm Transplantation; Nuclear Proteins; Oncogene Proteins, Fusion; Promoter Regions, Genetic; Recombinant Fusion Proteins; RNA-Binding Protein FUS; Thiazoles; Transcription Factor CHOP; Transcription Factors; Transformation, Genetic | 1997 |
Differential chemosensitivity in oncogene-transformed cells.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Cell Division; Cell Line; Cell Transformation, Neoplastic; Coloring Agents; Drug Resistance, Neoplasm; Intercalating Agents; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Oncogenes; Rats; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1996 |
Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies.
Topics: 3T3 Cells; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Binding Sites, Antibody; Breast Neoplasms; Cell Transformation, Neoplastic; Cross Reactions; Epitopes; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunoglobulin Variable Region; Male; Mice; Models, Molecular; Prostatic Neoplasms; Rats; Receptor, ErbB-2; Tetrazolium Salts; Thiazoles; Trastuzumab | 1999 |
Effects of proteasome inhibitor PSI on neoplastic and non-transformed cell lines.
Topics: Algorithms; Animals; Cell Division; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Cysteine Endopeptidases; Genes, ras; Humans; Mice; Multienzyme Complexes; Oligopeptides; Protease Inhibitors; Proteasome Endopeptidase Complex; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Cytotoxicity of synthetic estrogen and related compounds in various tumor-derived cells.
Topics: 3T3 Cells; Animals; Antineoplastic Agents, Hormonal; Cell Survival; Cell Transformation, Neoplastic; Diethylstilbestrol; Drug Screening Assays, Antitumor; Estradiol Congeners; Humans; KB Cells; Leukemia L1210; Mice; Oncogenes; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells.
Topics: Animals; Cell Division; Cell Transformation, Neoplastic; Cyclooxygenase 2; Enzyme Induction; Epoprostenol; Genes, ras; Intestinal Mucosa; Intestines; Isoenzymes; Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; ras Proteins; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Signal Transduction; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.
Topics: Animals; Cell Membrane; Cell Membrane Permeability; Cell Transformation, Neoplastic; Epithelium; FANFT; Humans; Intercellular Junctions; Male; Microscopy, Electron; Neoplasms, Experimental; Rats; Thiazoles; Urinary Bladder; Urinary Bladder Neoplasms | 1977 |
Oxidative stress and tumour cell proliferation.
Topics: Animals; Antigens, Polyomavirus Transforming; Cell Division; Cell Line; Cell Line, Transformed; Cell Transformation, Neoplastic; Cricetinae; Culture Media; Fibroblasts; Free Radicals; HeLa Cells; Hydrogen Peroxide; Mesocricetus; Oncogene Protein p21(ras); Oxidation-Reduction; Oxygen; Paraquat; Rats; Superoxides; Tetrazolium Salts; Thiazoles; Vitamin E | 1990 |
[Malignant transformation of NIH 3T3 cells by urine NTCA in normal population of Lin-xian County].
Topics: Animals; Cell Transformation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Nitroso Compounds; Rats; Thiazoles; Thiazolidines | 1989 |
Identification of inhibitory growth factors from a N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder cancer cell line.
Topics: Animals; Carcinoma, Transitional Cell; Cell Line; Cell Transformation, Neoplastic; Chromatography, Gel; Chromatography, High Pressure Liquid; FANFT; Growth Substances; Mice; Peptides; Rats; Thiazoles; Transforming Growth Factors; Urinary Bladder Neoplasms | 1987 |